ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 106

$652K Total Retail Price of All Prescriptions

Rank: 9 out of 106

589 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 589 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,757 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 52%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $135 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
PRAVASTATIN SODIUM 474 369 1 24
OMEPRAZOLE 469 380 2 8
LISINOPRIL 363 301 3 20
SIMVASTATIN 362 273 4 19
THEOPHYLLINE ANHYDROUS 351 275 5 12
FUROSEMIDE 330 254 6 11
PREDNISONE 329 237 7 3
ADVAIR DISKUS 298 202 8 2
POTASSIUM CHLORIDE 260 169 9 22
RANITIDINE HCL 252 210 10 48
LEVOTHYROXINE SODIUM 239 193 11 16
AMLODIPINE BESYLATE 218 182 12 18
CLONIDINE HCL 214 204 13 37
HYDROCODONE-ACETAMINOPHEN 208 174 S3 14 7
METHYLPREDNISOLONE 193 156 15 25
GABAPENTIN 184 133 16 23
DOXYCYCLINE HYCLATE 178 122 17 30
VENTOLIN HFA 176 95 18 6
WARFARIN SODIUM 163 131 19 27
MELOXICAM 159 140 20 26
SPIRIVA 157 104 21 1
METFORMIN HCL 157 131 21 29
SYMBICORT 156 128 23 5
PROAIR HFA 148 92 24 4
METOPROLOL TARTRATE 147 120 25 34
LOSARTAN POTASSIUM 146 109 26 42
METFORMIN HCL ER 133 109 27 73
ZOLPIDEM TARTRATE 132 102 28 13
GLIMEPIRIDE 128 103 29 70
SPIRONOLACTONE 128 102 29 62
SINGULAIR 119 90 31 9
ATENOLOL 113 88 32 39
NEXIUM 113 86 32 28
DIGOXIN 107 92 34 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 94 35 64
CARVEDILOL 105 88 36 40
AZITHROMYCIN 104 87 37 10
SERTRALINE HCL 102 85 38 46
FLUTICASONE PROPIONATE 93 82 39 15
BISOPROLOL-HYDROCHLOROTHIAZIDE 92 72 40 97
ATORVASTATIN CALCIUM 89 68 41 35
FENOFIBRATE 87 50 42 99
COMBIVENT 85 44 43 14
LEVOFLOXACIN 85 66 43 21
PANTOPRAZOLE SODIUM 83 58 45 31
METOPROLOL SUCCINATE 83 68 45 47
PAROXETINE HCL 81 78 47 103
KLOR-CON 10 81 65 47 81
HYDROCHLOROTHIAZIDE 80 59 49 41
FLUOXETINE HCL 80 74 49 104
TRIAMTERENE-HCTZ 77 71 51 56
CLOPIDOGREL 72 65 52 71
TAMSULOSIN HCL 71 67 53 50
ALENDRONATE SODIUM 70 70 54 53
CIPROFLOXACIN HCL 69 61 55 36
MONTELUKAST SODIUM 69 46 55 17
CARBIDOPA-LEVODOPA 68 55 57 57
ALLOPURINOL 67 51 58 51
TRAZODONE HCL 64 52 59 38
ETODOLAC 63 54 60 117
ROPINIROLE HCL 61 56 61 33
PLAVIX 58 53 62 120
LOVASTATIN 56 39 63 72
DONEPEZIL HCL 56 55 63 122
FLUCONAZOLE 53 35 65 125
LANTUS 53 49 65 125
PROMETHAZINE HCL 50 28 R 67 85
QUINAPRIL HCL 50 37 67 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.